4//SEC Filing
Feldmann Marc 4
Accession 0001213900-21-064981
CIK 0001690080other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:18 PM ET
Size
9.3 KB
Accession
0001213900-21-064981
Insider Transaction Report
Form 4
Feldmann Marc
Director10% Owner
Transactions
- Award
Common Stock
2021-12-08$3.95/sh+5,536$21,867→ 2,759,930 total - Purchase
Common Stock
2021-12-09$4.07/sh+50,000$203,500→ 2,809,930 total - Award
Stock Option (Right to Buy)
2021-12-08+25,000→ 25,000 totalExercise: $3.95From: 2021-12-08Exp: 2031-12-08→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]Granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.
- [F2]Represents shares of common stock issued in consideration for a net of $21,870 of compensation owed to the Reporting Person after the deduction for taxes for services rendered to the Company as a member of the Board of Directors.
- [F3]This transaction was executed in multiple trades at prices ranging from $4.05 to $4.10. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001832327
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:18 PM ET
- Size
- 9.3 KB